13 research outputs found
An NGQD Based Diagnostic Tool for Pancreatic Cancer
Background: Pancreatic cancer remains difficult to detect at early stages which contributes to a poor five-yearsurvival rate. Therefore, early detection approaches based on novel technologies should be explored to address this critical health issue. Nanomaterials have recently emerged as frontrunners for diagnostic applications due to their small size in the 1-100 nm range, which facilitates one-on-one interactions with a variety of biomolecules like oligonucleotides and makes them suitable for a plethora of detection and delivery applications. In this work, the presence of specific pancreatic cancer miRNA (pre-miR-132) is detected utilizing the fluorescence properties of highly biocompatible nitrogen-doped graphene quantum dots (NGQDs).
Methods: NGQDs were synthesized from Glucosamine HCl and deionized H2O. Cuvettes were filled with a mixture of bait ssDNA (13.7μM) and NGQDs (0.5 mg/ml) in deionized H2O that was vortexed for 5s before adding target strands. Samples were again vortexed for 5s and incubated at 4 ºC for 2hrs before excitation at 400 nm with an emission wavelength measured from 420 nm to 780 nm using a spectrofluorometer. Data analysis was performed using Origin software.
Results: From the Zeta potential measurements, this platform is comprised of positively charged (1.14±0.36 mV) NGQDs binding with negatively charged (-22.4±6.00 mV) ssDNA electrostatically and/or via − stacking to form an NGQDs/ssDNA complex with an estimated size of 20 nm verified with TEM. Observing variations in fluorescence spectra of NGQDs/ssDNA complexes allows for the distinguishing of single-stranded and double-stranded DNA, as well as specific single-stranded DNA sequences due to bait-target complementarity. Furthermore, this enables detection of the loop of pre-miRNA of interest and can identify target miRNA from random controls with sensitivity in the nanomolar range.
Conclusions: This approach allows for pancreatic cancer-specific miRNA sensing to facilitate pancreatic cancer detection at the early stages. Such early diagnosis is ultimately aimed to increase cancer patient survival rates
Detection of Pancreatic Cancer miRNA with Biocompatible Nitrogen-Doped Graphene Quantum Dots
Early-stage pancreatic cancer remains challenging to detect, leading to a poor five-year patient survival rate. This obstacle necessitates the development of early detection approaches based on novel technologies and materials. In this work, the presence of a specific pancreatic cancer-derived miRNA (pre-miR-132) is detected using the fluorescence properties of biocompatible nitrogen-doped graphene quantum dots (NGQDs) synthesized using a bottom-up approach from a single glucosamine precursor. The sensor platform is comprised of slightly positively charged (1.14 ± 0.36 mV) NGQDs bound via π-π stacking and/or electrostatic interactions to the negatively charged (-22.4 ± 6.00 mV) bait ssDNA; together, they form a complex with a 20 nm average size. The NGQDs\u27 fluorescence distinguishes specific single-stranded DNA sequences due to bait-target complementarity, discriminating them from random control sequences with sensitivity in the micromolar range. Furthermore, this targetability can also detect the stem and loop portions of pre-miR-132, adding to the practicality of the biosensor. This non-invasive approach allows cancer-specific miRNA detection to facilitate early diagnosis of various forms of cancer
Effects of Doxorubicin Delivery by Nitrogen-Doped Graphene Quantum Dots on Cancer Cell Growth: Experimental Study and Mathematical Modeling
With 18 million new cases diagnosed each year worldwide, cancer strongly impacts both science and society. Current models of cancer cell growth and therapeutic efficacy in vitro are time-dependent and often do not consider the Emax value (the maximum reduction in the growth rate), leading to inconsistencies in the obtained IC50 (concentration of the drug at half maximum effect). In this work, we introduce a new dual experimental/modeling approach to model HeLa and MCF-7 cancer cell growth and assess the efficacy of doxorubicin chemotherapeutics, whether alone or delivered by novel nitrogen-doped graphene quantum dots (N-GQDs). These biocompatible/biodegradable nanoparticles were used for the first time in this work for the delivery and fluorescence tracking of doxorubicin, ultimately decreasing its IC50 by over 1.5 and allowing for the use of up to 10 times lower doses of the drug to achieve the same therapeutic effect. Based on the experimental in vitro studies with nanomaterial-delivered chemotherapy, we also developed a method of cancer cell growth modeling that (1) includes an Emax value, which is often not characterized, and (2), most importantly, is measurement time-independent. This will allow for the more consistent assessment of the efficiency of anti-cancer drugs and nanomaterial-delivered formulations, as well as efficacy improvements of nanomaterial delivery
Multi-Drug/Gene NASH Therapy Delivery and Selective Hyperspectral NIR Imaging Using Chirality-Sorted Single-Walled Carbon Nanotubes
Single-walled carbon nanotubes (SWCNTs) can serve as drug delivery/biological imaging agents, as they exhibit intrinsic fluorescence in the near-infrared, allowing for deeper tissue imaging while providing therapeutic transport. In this work, CoMoCAT (Cobalt Molybdenum Catalyst) SWCNTs, chirality-sorted by aqueous two-phase extraction, are utilized for the first time to deliver a drug/gene combination therapy and image each therapeutic component separately via chirality-specific SWCNT fluorescence. Each of (7,5) and (7,6) sorted SWCNTs were non-covalently loaded with their specific payload: the PI3 kinase inhibitor targeting liver fibrosis or CCR5 siRNA targeting inflammatory pathways with the goal of addressing these processes in nonalcoholic steatohepatitis (NASH), ultimately to prevent its progression to hepatocellular carcinoma. PX-866-(7,5) SWCNTs and siRNA-(7,6) SWCNTs were each imaged via characteristic SWCNT emission at 1024/1120 nm in HepG2 and HeLa cells by hyperspectral fluorescence microscopy. Wavelength-resolved imaging verified the intracellular transport of each SWCNT chirality and drug release. The therapeutic efficacy of each formulation was further demonstrated by the dose-dependent cytotoxicity of SWCNT-bound PX-866 and >90% knockdown of CCR5 expression with SWCNT/siRNA transfection. This study verifies the feasibility of utilizing chirality-sorted SWCNTs for the delivery and component-specific imaging of combination therapies, also suggesting a novel nanotherapeutic approach for addressing the progressions of NASH to hepatocellular carcinoma
Detection of Pancreatic Cancer miRNA with Biocompatible Nitrogen-Doped Graphene Quantum Dots
Early-stage pancreatic cancer remains challenging to detect, leading to a poor five-year patient survival rate. This obstacle necessitates the development of early detection approaches based on novel technologies and materials. In this work, the presence of a specific pancreatic cancer-derived miRNA (pre-miR-132) is detected using the fluorescence properties of biocompatible nitrogen-doped graphene quantum dots (NGQDs) synthesized using a bottom-up approach from a single glucosamine precursor. The sensor platform is comprised of slightly positively charged (1.14 ± 0.36 mV) NGQDs bound via π−π stacking and/or electrostatic interactions to the negatively charged (−22.4 ± 6.00 mV) bait ssDNA; together, they form a complex with a 20 nm average size. The NGQDs’ fluorescence distinguishes specific single-stranded DNA sequences due to bait–target complementarity, discriminating them from random control sequences with sensitivity in the micromolar range. Furthermore, this targetability can also detect the stem and loop portions of pre-miR-132, adding to the practicality of the biosensor. This non-invasive approach allows cancer-specific miRNA detection to facilitate early diagnosis of various forms of cancer
Chapter 7 Gene Transfer to Muscle and Spinal Cord Using Herpes Simplex Virus-Based Vectors
--
Multi-Drug/Gene NASH Therapy Delivery and Selective Hyperspectral NIR Imaging Using Chirality-Sorted Single-Walled Carbon Nanotubes
Synthesis, Characterization, and Activity of a Triazine Bridged Antioxidant Small Molecule
Metal-ion misregulation and
oxidative stress continue to be components of the continually evolving
hypothesis describing the molecular origins of Alzheimer’s
disease. Therefore, these features are viable targets for synthetic
chemists to explore through hybridizations of metal-binding ligands
and antioxidant units. To date, the metal-binding unit in potential
therapeutic small molecules has largely been inspired by clioquinol
with the exception of a handful of heterocyclic small molecules and
open-chain systems. Heterocyclic small molecules such as cyclen (1,4,7,10-tetraazacyclododecane)
have the advantage of straightforward N-based modifications, allowing
the addition of functional groups. In this work, we report the synthesis
of a triazine bridged system containing two cyclen metal-binding units
and an antioxidant coumarin appendage inspired by nature. This new
potential therapeutic molecule shows the ability to bind copper in
a unique manner compared to other chelates proposed to treat Alzheimer’s
disease. DPPH and TEAC assays exploring the activity of <i>N</i>-(2-((4,6-di(1,4,7,10-tetraazacyclododecan-1-yl)-1,3,5-triazin-2-yl)amino)ethyl)-2-oxo-2<i>H</i>-chromene-3-carboxamide (molecule <b>1</b>) show
that the molecule is antioxidant. Cellular studies of molecule <b>1</b> indicate a low toxicity (EC<sub>50</sub> = 80 μM)
and the ability to protect HT-22 neuronal cells from cell death induced
by Aβ + copper(II), thus demonstrating the potential for molecule <b>1</b> to serve as a multimodal therapeutic for Alzheimer’s
disease